These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23949591)

  • 41. Demographic and behavioural factors associated with antimicrobial susceptibility to azithromycin and ceftriaxone in
    Forster RF; Smith M; Cooper G; Brokenshire M; Roberts SA; McAuliffe GN
    Int J STD AIDS; 2021 Jan; 32(1):67-74. PubMed ID: 33198606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains.
    Whiley DM; Jacobsson S; Tapsall JW; Nissen MD; Sloots TP; Unemo M
    J Antimicrob Chemother; 2010 Dec; 65(12):2543-7. PubMed ID: 20940180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neisseria gonorrhoeae with reduced susceptibility to azithromycin--San Diego County, California, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(18):579-81. PubMed ID: 21566558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimicrobial Susceptibility of Neisseria gonorrhoeae in Japan from 2000 to 2015.
    Yasuda M; Hatazaki K; Ito S; Kitanohara M; Yoh M; Kojima M; Narita H; Kido A; Miyata K; Deguch T
    Sex Transm Dis; 2017 Mar; 44(3):149-153. PubMed ID: 28178112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emerging azithromycin-resistance among the Neisseria gonorrhoeae strains isolated in Hungary.
    Brunner A; Nemes-Nikodem E; Jeney C; Szabo D; Marschalko M; Karpati S; Ostorhazi E
    Ann Clin Microbiol Antimicrob; 2016 Sep; 15(1):53. PubMed ID: 27646968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of Neisseria gonorrhoeae MICs obtained by Etest and agar dilution for ceftriaxone, cefpodoxime, cefixime and azithromycin.
    Gose S; Kong CJ; Lee Y; Samuel MC; Bauer HM; Dixon P; Soge OO; Lei J; Pandori M
    J Microbiol Methods; 2013 Dec; 95(3):379-80. PubMed ID: 24455772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resistance to Ceftriaxone and Azithromycin in Neisseria gonorrhoeae Isolates From 7 Countries of South America and the Caribbean: 2010-2011.
    Thakur SD; Araya P; Borthagaray G; Galarza P; Hernandez AL; Payares D; Sanabria Cruz OM; Carvallo ME; Corredor AH; Dillon JR
    Sex Transm Dis; 2017 Mar; 44(3):157-160. PubMed ID: 28178114
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emergence of quinolone resistance and cephalosporin MIC creep in Neisseria gonorrhoeae isolates from a cohort of young men in Kisumu, Kenya, 2002 to 2009.
    Mehta SD; Maclean I; Ndinya-Achola JO; Moses S; Martin I; Ronald A; Agunda L; Murugu R; Bailey RC; Melendez J; Zenilman JM
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3882-8. PubMed ID: 21606224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetic Data Are Predictive of
    Connolly KL; Eakin AE; Gomez C; Osborn BL; Unemo M; Jerse AE
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada.
    Allen VG; Mitterni L; Seah C; Rebbapragada A; Martin IE; Lee C; Siebert H; Towns L; Melano RG; Low DE
    JAMA; 2013 Jan; 309(2):163-70. PubMed ID: 23299608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.
    Lee SG; Lee H; Jeong SH; Yong D; Chung GT; Lee YS; Chong Y; Lee K
    J Antimicrob Chemother; 2010 Apr; 65(4):669-75. PubMed ID: 20093260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimicrobial Resistance of Neisseria Gonorrhoeae in a Newly Implemented Surveillance Program in Uganda: Surveillance Report.
    Workneh M; Hamill MM; Kakooza F; Mande E; Wagner J; Mbabazi O; Mugasha R; Kajumbula H; Walwema R; Zenilman J; Musinguzi P; Kyambadde P; Lamorde M; Manabe YC
    JMIR Public Health Surveill; 2020 Jun; 6(2):e17009. PubMed ID: 32519969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimicrobial susceptibilities and molecular typing of neisseria gonorrhoeae isolates at a medical centre in Taiwan, 2001-2013 with an emphasis on high rate of azithromycin resistance among the isolates.
    Liu YH; Huang YT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2018 May; 51(5):768-774. PubMed ID: 29477549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.
    Unemo M; Golparian D; Nicholas R; Ohnishi M; Gallay A; Sednaoui P
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1273-80. PubMed ID: 22155830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013.
    Hamasuna R; Yasuda M; Ishikawa K; Uehara S; Hayami H; Takahashi S; Matsumoto T; Yamamoto S; Minamitani S; Watanabe A; Iwata S; Kaku M; Kadota J; Sunakawa K; Sato J; Hanaki H; Tsukamoto T; Kiyota H; Egawa S; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Kobayashi K; Matsubara A; Naito S; Kuroiwa K; Hirayama H; Narita H; Hosobe T; Ito S; Ito K; Kawai S; Ito M; Chokyu H; Matsumura M; Yoshioka M; Uno S; Monden K; Takayama K; Kaji S; Kawahara M; Sumii T; Kadena H; Yamaguchi T; Maeda S; Nishi S; Nishimura H; Shirane T; Yoh M; Akiyama K; Imai T; Kano M
    J Infect Chemother; 2015 May; 21(5):340-5. PubMed ID: 25727286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations.
    Tomberg J; Unemo M; Davies C; Nicholas RA
    Biochemistry; 2010 Sep; 49(37):8062-70. PubMed ID: 20704258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination therapy for gonorrhoea: in vitro synergy testing.
    Pereira R; Cole MJ; Ison CA
    J Antimicrob Chemother; 2013 Mar; 68(3):640-3. PubMed ID: 23152483
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased Cephalosporin Susceptibility of Oropharyngeal Neisseria Species in Antibiotic-using Men Who Have Sex With Men in Hanoi, Vietnam.
    Dong HV; Pham LQ; Nguyen HT; Nguyen MXB; Nguyen TV; May F; Le GM; Klausner JD
    Clin Infect Dis; 2020 Mar; 70(6):1169-1175. PubMed ID: 31049592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antimicrobial resistance and molecular characterisation of Neisseria gonorrhoeae isolates in Fukuoka, Japan, 1996-2016.
    Tanaka M; Furuya R; Kobayashi I; Kanesaka I; Ohno A; Katsuse AK
    J Glob Antimicrob Resist; 2019 Jun; 17():3-7. PubMed ID: 30448519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):590-4. PubMed ID: 22874837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.